A Study to Learn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis.
NCT05387980 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1128
Last updated 2026-03-19
Summary
The purpose of this study is to learn about the safety and effectiveness (how well the study treatment works) of the study medicine (CIBINQO) for the potential treatment of atopic dermatitis in people under Japanese medical practice.
Conditions
Interventions
- DRUG
-
CIBINQO
Patients receiving CIBINQO tablets by mouth for the treatment of Atopic Dermatitis.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-04-19
- Primary Completion
- 2028-11-01
- Completion
- 2028-11-01
Countries
- Japan
Study Locations
More Related Trials
-
Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients With Atopic Dermatitis
NCT00232011 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of JNJ-39758979 in Adult Japanese Patients With Moderate Atopic Dermatitis
NCT01497119 ·Status: TERMINATED ·Phase: PHASE2
-
A STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF MULTIPLE SUBCUTANEOUS INJECTIONS OF SHR-1819 IN PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
NCT05197023 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Evaluate the Safety and Efficacy of CBP-201 in Chinese Adult Subjects With Moderate to Severe AD
NCT05905133 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Dupilumab-pediatric Skin Barrier Function and Lipidomics Study in Patients With Atopic Dermatitis in China
NCT05680298 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Impact of Lebrikizumab on Health-Related Well-Being and Control of Skin Manifestations in Participants With Moderate-to-Severe Atopic Dermatitis
NCT06815380 ·Status: RECRUITING
-
Open-label Study of Dupilumab in Patients With Atopic Dermatitis
NCT01949311 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Safety of Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
NCT03661138 ·Status: COMPLETED ·Phase: PHASE3
-
This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects with Moderate to Severe Atopic Dermatitis (AD).
NCT05935085 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Assess Change in Disease Activity in Adolescents and Adults With Moderate to Severe Prurigo-type Atopic Dermatitis in Japan Who Are Treated With Oral Upadacitinib
NCT05451316 ·Status: COMPLETED
-
A Study of Lebrikizumab in Combination With Topical Corticosteroids in Patients With Atopic Dermatitis (AD) That Are Not Adequately Controlled With or Are Non-eligible for Cyclosporine
NCT05149313 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of CBP-201 in Moderate to Severe Atopic Dermatitis in China
NCT05017480 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety, Tolerability and Pharmacokinetic Study of LEO 29102 in Subjects With Atopic Dermatitis
NCT01005823 ·Status: COMPLETED ·Phase: PHASE1
-
A First-In-Human Study to Evaluate the Safety, Tolerability, and Efficacy of Si-544 in Adults With Atopic Dermatitis
NCT05383378 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis
NCT05990725 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study to Learn About Abrocitinib Tablets in People With Atopic Dermatitis in India
NCT05375929 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of (LY3650150) Lebrikizumab to Assess the Safety and Efficacy of Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of Color
NCT05372419 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase I Clinical Study to Evaluate SM17 in Chinese Healthy Subjects and Patients With Moderate to Severe Atopic Dermatitis
NCT07103369 ·Status: COMPLETED ·Phase: PHASE1
-
Dose-Finding Study of M516102 in the Treatment of Pruritus Associated With Atopic Dermatitis
NCT00980629 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.
NCT05689151 ·Status: RECRUITING
-
Effects of Abrocitinib in Subjects With Atopic Dermatitis With an Unsatisfactory Response After Treatment With Dupilumab
NCT05602207 ·Status: COMPLETED ·Phase: PHASE4
-
Long-term Safety and Efficacy of Lebrikizumab in Adult and Adolescent Participant With Moderate-to-Severe Atopic Dermatitis
NCT05916365 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of E6005 in Japanese Patients With Atopic Dermatitis
NCT01179880 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Assess Efficacy and Safety of Two Regimens of Crisaborole Ointment 2% in Japanese Participants Aged ≥2 Years With Mild to Moderate Atopic Dermatitis
NCT03954158 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Efficacy and Safety of CBP-201 in Adult Subjects With Moderate to Severe Atopic Dermatitis
NCT04444752 ·Status: COMPLETED ·Phase: PHASE2